Novel Antiplatelet and Anticoagulant Agents in the Cardiac Care Unit

Vaani Panse Garg; Jonathan L. Halperin

doi:10.1016/j.ccl.2013.07.001

Novel Antiplatelet and Anticoagulant Agents in the Cardiac Care Unit

Vaani Panse Garg, Jonathan L. Halperin

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

This article reviews the pivotal studies of several novel antiplatelet (prasugrel and ticagrelor) and anticoagulant (dabigatran, rivaroxaban, and apixaban) agents. The clinical use of these drugs in cardiac intensive care is discussed, focusing on the management of acute coronary syndromes, ischemic stroke, atrial fibrillation, and venous thromboembolism.

Original language	English
Pages (from-to)	533-544
Number of pages	12
Journal	Cardiology Clinics
Volume	31
Issue number	4
DOIs	https://doi.org/10.1016/j.ccl.2013.07.001
State	Published - Nov 2013

Keywords

Acute coronary syndrome
Anticoagulants
Antiplatelet drugs
Atrial fibrillation
Percutaneous coronary intervention
Stroke
Venous thromboembolism

Access to Document

10.1016/j.ccl.2013.07.001

Cite this

@article{7d633c91f0834c158640aa47cc0bb993,

title = "Novel Antiplatelet and Anticoagulant Agents in the Cardiac Care Unit",

abstract = "This article reviews the pivotal studies of several novel antiplatelet (prasugrel and ticagrelor) and anticoagulant (dabigatran, rivaroxaban, and apixaban) agents. The clinical use of these drugs in cardiac intensive care is discussed, focusing on the management of acute coronary syndromes, ischemic stroke, atrial fibrillation, and venous thromboembolism.",

keywords = "Acute coronary syndrome, Anticoagulants, Antiplatelet drugs, Atrial fibrillation, Percutaneous coronary intervention, Stroke, Venous thromboembolism",

author = "Garg, \{Vaani Panse\} and Halperin, \{Jonathan L.\}",

year = "2013",

month = nov,

doi = "10.1016/j.ccl.2013.07.001",

language = "English",

volume = "31",

pages = "533--544",

journal = "Cardiology Clinics",

issn = "0733-8651",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - Novel Antiplatelet and Anticoagulant Agents in the Cardiac Care Unit

AU - Garg, Vaani Panse

AU - Halperin, Jonathan L.

PY - 2013/11

Y1 - 2013/11

N2 - This article reviews the pivotal studies of several novel antiplatelet (prasugrel and ticagrelor) and anticoagulant (dabigatran, rivaroxaban, and apixaban) agents. The clinical use of these drugs in cardiac intensive care is discussed, focusing on the management of acute coronary syndromes, ischemic stroke, atrial fibrillation, and venous thromboembolism.

AB - This article reviews the pivotal studies of several novel antiplatelet (prasugrel and ticagrelor) and anticoagulant (dabigatran, rivaroxaban, and apixaban) agents. The clinical use of these drugs in cardiac intensive care is discussed, focusing on the management of acute coronary syndromes, ischemic stroke, atrial fibrillation, and venous thromboembolism.

KW - Acute coronary syndrome

KW - Anticoagulants

KW - Antiplatelet drugs

KW - Atrial fibrillation

KW - Percutaneous coronary intervention

KW - Stroke

KW - Venous thromboembolism

UR - https://www.scopus.com/pages/publications/84887026408

U2 - 10.1016/j.ccl.2013.07.001

DO - 10.1016/j.ccl.2013.07.001

M3 - Review article

C2 - 24188219

AN - SCOPUS:84887026408

SN - 0733-8651

VL - 31

SP - 533

EP - 544

JO - Cardiology Clinics

JF - Cardiology Clinics

IS - 4

ER -

Novel Antiplatelet and Anticoagulant Agents in the Cardiac Care Unit

Abstract

Keywords

Access to Document

Fingerprint

Cite this